Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Res Social Adm Pharm ; 14(12): 1195-1202, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-29523395

RESUMEN

BACKGROUND: Data from large electronic databases are increasingly used in epidemiological research, but golden standards for database validation remain elusive. The Prescription Registry (IPR) and the National Health Service (NHS) databases in Iceland have not undergone formal validation, and gross errors have repeatedly been found in Icelandic statistics on pharmaceuticals. In 2015, new amphetamine tablets entered the Icelandic market, but were withdrawn half a year later due to being substandard. Return of unused stocks provided knowledge of the exact number of tablets used and hence a case where quality of the data could be assessed. OBJECTIVE: A case study of the quality of statistics in a national database on pharmaceuticals. METHODS: Data on the sales of the substandard amphetamine were obtained from the Prescription Registry and the pharmaceuticals statistics database. Upon the revelation of discrepancies, explanations were sought from the respective institutions, the producer, and dose dispensing companies. RESULTS: The substandard amphetamine was available from 1.9.2015 until 15.3.2016. According to NHS, 73990 tablets were sold to consumers in that period, whereas IPR initially stated 82860 tablets to have been sold, correcting to 74796 upon being notified about errors. The producer stated 72811 tablets to have been sold, and agreed with the dose dispensing companies on sales to those. The producer's numbers were confirmed by the Medicines Agency. CONCLUSION: Over-registration in the IPR was 13.8% before correction, 2.7% after correction, and 1.6% in the NHS. This case provided a unique opportunity for external validation of sales data for pharmaceuticals in Iceland, revealing enormous quality problems. The case has implications regarding database integrity beyond Iceland.


Asunto(s)
Anfetamina/normas , Macrodatos , Bases de Datos Factuales/estadística & datos numéricos , Sistema de Registros/estadística & datos numéricos , Anfetamina/economía , Anfetamina/provisión & distribución , Comercio/estadística & datos numéricos , Interpretación Estadística de Datos , Bases de Datos Factuales/normas , Industria Farmacéutica/estadística & datos numéricos , Humanos , Islandia , Sistema de Registros/normas , Comprimidos
2.
J Psychopharmacol ; 25(11): 1543-7, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20826554

RESUMEN

Recently, several reports have indicated instability of the ecstasy market in the Netherlands and other EU countries. In the current study, we demonstrate this instability in the Netherlands, showing a decrease of ecstasy tablets containing 3,4-methylenedioxymetamphetamine (MDMA) by more than 50% in 2009. In addition, we describe a partial replacement of MDMA in tablets sold as ecstasy by a previously unseen substance, mephedrone (or 4-methylmethcathinone). Mephedrone was quantified and ecstasy tablets contained between 96 and 155 mg of this new compound. So far, no studies about mephedrone's effects have been published. For this study, we gathered information on the acute subjective effects of mephedrone from 70 regular ecstasy users. Overall, the majority of users considered the effects enjoyable. Mephedrone seemed to evoke effects similar to other amphetamine type psychostimulants, including MDMA. In contrast to MDMA, however, mephedrone induced strong feelings of craving in most users. If the unstable ecstasy market situation persists, the potential of mephedrone to substitute for MDMA might be substantial. Mephedrone, sold as ecstasy, is therefore likely to be a valid cause for health concern.


Asunto(s)
Drogas Ilícitas/provisión & distribución , Metanfetamina/análogos & derivados , N-Metil-3,4-metilenodioxianfetamina/provisión & distribución , Anfetamina/provisión & distribución , Humanos , Metanfetamina/provisión & distribución , Países Bajos , Comprimidos
4.
Ugeskr Laeger ; 170(1): 54-7, 2008 Jan 07.
Artículo en Danés | MEDLINE | ID: mdl-18208718

RESUMEN

INTRODUCTION: A description of the illicit drug market in Denmark's second largest city is provided based upon the prevalence of narcotics and illicitly sold medicals during the years 2002 and 2003. The changes on the illicit drug market are described by comparing the results to a similar study conducted ten years earlier. MATERIALS AND METHODS: The study is comprised of 469 cases of seized material by Aarhus Police during the period January 1st 2002-December 31st 2003. Additional information relating to the 341 persons charged is also included in the study. RESULTS: Heroine, cocaine and amphetamine were seized in 31%, 30% and 28% of the cases, respectively, and comprise the most frequently encountered hard drugs on the market. The prevalence of cocaine in Aarhus Police District has increased more than tenfold during the past ten years. The purity of the three drugs decreased significantly during the same period, although large variations in the quality of drugs were observed. Medicals were found in 16% of the seizures (containing 32 different active substances). The most frequent group of medicals was benzodiazepines, which made up a total of 74% of the medicals in the study. Anabolic steroids, ecstasy and methamphetamine were each found in 4% of the seizures. Men with an average age of 29.1 years comprised 92% of the persons charged in the study. Persons with a foreign nationality comprised 15% of the charged, while 25% had a birthplace outside Denmark. CONCLUSION: The prevalence of stimulants especially cocaine have increased significantly during the past ten years. Meanwhile the purity of the drugs has decreased. The benzodiazepines are still the most frequent group of medicals on the illicit market.


Asunto(s)
Drogas Ilícitas , Narcóticos , Adulto , Anfetamina/provisión & distribución , Cocaína/provisión & distribución , Crimen , Dinamarca/epidemiología , Femenino , Heroína/provisión & distribución , Humanos , Drogas Ilícitas/legislación & jurisprudencia , Drogas Ilícitas/provisión & distribución , Masculino , Persona de Mediana Edad , Narcóticos/provisión & distribución , Prevalencia , Trastornos Relacionados con Sustancias/epidemiología
5.
BMC Public Health ; 6: 200, 2006 Aug 03.
Artículo en Inglés | MEDLINE | ID: mdl-16884546

RESUMEN

BACKGROUND: In early 2001 Australia experienced a sudden reduction in the availability of heroin which had widespread effects on illicit drug markets across the country. The consequences of this event, commonly referred to as the Australian 'heroin shortage', have been extensively studied and there has been considerable debate as to the causes of the shortage and its implications for drug policy. This paper aims to investigate the presence of these epidemic patterns, to quantify the scale over which they occur and to estimate the relative importance of the 'heroin shortage' and any epidemic patterns in the drug markets. METHOD: Key indicator data series from the New South Wales illicit drug market were analysed using the statistical methods Principal Component Analysis and SiZer. RESULTS: The 'heroin shortage' represents the single most important source of variation in this illicit drug market. Furthermore the size of the effect of the heroin shortage is more than three times that evidenced by long-term 'epidemic' patterns. CONCLUSION: The 'heroin shortage' was unlikely to have been a simple correction at the end of a long period of reduced heroin availability, and represents a separate non-random shock which strongly affected the markets.


Asunto(s)
Trastornos Relacionados con Anfetaminas/epidemiología , Trastornos Relacionados con Cocaína/epidemiología , Control de Medicamentos y Narcóticos/tendencias , Dependencia de Heroína/mortalidad , Heroína/provisión & distribución , Drogas Ilícitas/provisión & distribución , Aplicación de la Ley , Anfetamina/economía , Anfetamina/provisión & distribución , Trastornos Relacionados con Anfetaminas/economía , Análisis por Conglomerados , Cocaína/economía , Cocaína/provisión & distribución , Trastornos Relacionados con Cocaína/economía , Control de Medicamentos y Narcóticos/economía , Heroína/economía , Dependencia de Heroína/economía , Humanos , Drogas Ilícitas/economía , Nueva Gales del Sur/epidemiología , Distribución Normal , Análisis de Componente Principal , Factores de Tiempo
6.
Forensic Sci Int ; 131(2-3): 162-70, 2003 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-12590056

RESUMEN

This article describes an investigation of illicit drugs at street level in six selected police districts in different regions of Denmark. The investigation was carried out during a 6-year period from 1995 to 2000. During the period, a total of 1244 samples were examined, as about 200 samples were seized each year. A total of 94% of the seized samples were familiar drugs: heroin base, heroin hydrochloride, cocaine hydrochloride and amphetamine sulphate. Only 2% of the samples contained designer drugs. From having constituted 53% of the samples in 1995, the frequency of heroin base fell during the period to 27% of the samples in 2000. The frequency of heroin hydrochloride was unchanged. In the same period, the frequency of cocaine hydrochloride increased from 10% of the samples in 1995 to about 25% of the samples in 2000. Apart from a few exceptions, cocaine had the same extension in all regions of Denmark after 1996. Amphetamine was more frequent in the west of Denmark, while heroin hydrochloride was more frequent in central Denmark. The purity of heroin base was lower in the period 1997-1999 than in the other years. During the entire period, the purity of cocaine hydrochloride and amphetamine sulphate fell, while the purity of heroin hydrochloride was unchanged. No significant differences between the various regions of Denmark were detected during the period in the purity of heroin hydrochloride, heroin base, cocaine hydrochloride or amphetamine sulphate. MDMA was the most frequent designer drug, but other types of designer drugs such as MDA and MDE and the less common PMA, PMMA and MBDB were also found.


Asunto(s)
Contaminación de Medicamentos/estadística & datos numéricos , Heroína/provisión & distribución , Drogas Ilícitas/análisis , Drogas Ilícitas/provisión & distribución , Narcóticos/provisión & distribución , Anfetamina/análisis , Anfetamina/provisión & distribución , Análisis de Varianza , Cocaína/análisis , Cocaína/provisión & distribución , Dinamarca/epidemiología , Embalaje de Medicamentos/métodos , Alucinógenos/análisis , Alucinógenos/provisión & distribución , Heroína/análisis , Humanos , N-Metil-3,4-metilenodioxianfetamina/análisis , N-Metil-3,4-metilenodioxianfetamina/provisión & distribución , Narcóticos/análisis , Estudios Prospectivos , Trastornos Relacionados con Sustancias/epidemiología
7.
Z Rechtsmed ; 102(8): 509-19, 1989.
Artículo en Alemán | MEDLINE | ID: mdl-2800729

RESUMEN

During the period of survey, the number of narcotic drug seizures by the law, especially cannabis resin, has increased considerably. The details on this development are presented. The following main analytical results were obtained: the median concentration of THC in cannabis resin has increased up to 8.6%, in cannabis plants the THC content has fluctuated between 1% and 3%. In the heroin samples since 1982, diamorphin has predominated in the base form; the diamorphin content had dropped to 32%, which is connected with a rise simultaneous in the concentration of noscapine (up to 9%). The concentration of cocaine hydrochloride had diminished at the end of the period to 62%; on the other hand, the amphetamine sulfate content increased to 69%. LSD trips used from 10 to 120 micrograms per trip. Methadone occurred mostly in the form of tablets containing 5 mg methadone hydrochloride.


Asunto(s)
Control de Medicamentos y Narcóticos/legislación & jurisprudencia , Drogas Ilícitas/provisión & distribución , Narcóticos/provisión & distribución , Trastornos Relacionados con Opioides/epidemiología , Anfetamina/provisión & distribución , Cocaína/provisión & distribución , Estudios Transversales , Alemania Occidental/epidemiología , Dependencia de Heroína/epidemiología , Humanos , Incidencia , Abuso de Marihuana/epidemiología , Trastornos Relacionados con Opioides/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA